AED 3 Defibrillator with Uni-Padz
ZOLL MEDICAL CORPORATION · Decision date Oct 16, 2026
What did the FDA approve?
FDA's database lists P160015/S029 for ZOLL Medical Corporation's AED 3 Defibrillator with Uni-Padz as a normal 180-day-track PMA supplement without user fee, approved 2026-10-16. The supplement reason is postapproval study protocol, and the statement describes approval of a protocol for the post-approval study to replace the original PAS protocol.
Because S029 is a supplement to P160015, it modifies an element of that existing approval rather than approving the device system anew. The statement says the submitted PAS protocol complies with conditions of approval in the P160015/S001 order. It does not report PAS results, so it is not evidence of safety or clinical effectiveness; the replacement protocol's design, endpoints and timeline are absent.
FDA approval order statement
approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2026
- FDA change category
- Postapproval Study Protocol
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160015/S029
- Regulatory pathway
- PMA supplement
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- Decision code
- APPR
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160015. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160015 · Original PMA
AED Plus and Fully Automatic AED Plus
P160015/S029 received
Application receipt date recorded by FDA.
P160015/S029 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P160015. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160015
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ZOLL MEDICAL CORPORATION | PMA approval | May 26, 2017 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
LIFEPAK 15 monitor/defibrillatorP160026/S073 | Physio-Control, Inc. | PMA supplement | Sep 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZOLL MEDICAL CORPORATION
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 269 & 271 Mill Rd., Chelsmford, MA, 01824
Sources and methodology
- Original FDA record: P160015/S029
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



